AORT - ARTIVION, INC.

23.99
0.260   1.084%

Share volume: 227,484
Last Updated: 04-29-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$23.73
0.26
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 12%
Dept financing 25%
Liquidity 54%
Performance 31%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.63%
1 Month
-2.40%
3 Months
-23.53%
6 Months
-9.91%
1 Year
22.27%
2 Year
70.87%
Key data
Stock price
$23.99
P/E Ratio 
0.00
DAY RANGE
$23.62 - $24.23
EPS 
-$0.32
52 WEEK RANGE
$20.32 - $32.33
52 WEEK CHANGE
$18.00
MARKET CAP 
1.198 B
YIELD 
N/A
SHARES OUTSTANDING 
41.893 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-05-2025
BETA 
0.94
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$320,632
AVERAGE 30 VOLUME 
$450,366
Company detail
CEO: James P. Mackin
Region: US
Website: artivion.com
Employees: 1,300
IPO year: 2006
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases.

Recent news
loading